Beckman Institute Director’s Seminar: Luthey-Schulten to present Nov. 5

Zaida “Zan” Luthey-Schulten, a part-time faculty member in the Theoretical and Computational Biophysics Group at the Beckman Institute for Advanced Science and Technology, will present “Stochastic Simulations of Cellular Processes: From Single Cells to Colonies.” The lecture will begin at noon Nov. 5 in Room 1005 of the Beckman Institute as part of the Beckman Institute Director’s Seminar. Lunch will be provided.

Luthey-Schulten is a Lycan Professor in the department of chemistry and also is affiliated with the Center for Biophysics and Computational Biology.

Twelve Illinois scientists rank among the world’s most influential

CHAMPAIGN, Ill. — Twelve scientists at the University of Illinois Urbana-Champaign have been named to the 2025 Clarivate Analytics Highly Cited Researchers list. The list recognizes researchers and social scientists who have demonstrated exceptional influence, as reflected through their publication of multiple papers frequently cited by their peers during the last decade. The highly cited […]

Engineering A tilted view of miscellaneous of multicolored used batteries.

Study shows new hope for commercially attractive lithium extraction from spent batteries

A new study shows that lithium — a critical element used in rechargeable batteries and susceptible to supply chain disruption — can be recovered from battery waste using an electrochemically driven recovery process. The method has been tested on commonly used types of lithium-containing batteries and demonstrates economic viability with the potential to simplify operations, minimize costs and increase the sustainability and attractiveness of the recovery process for commercial use.

Health and Medicine Research team in the lab.

Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy

CHAMPAIGN, Ill. — A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers report. The protein, FGD3, contributes to the rupture of cancer cells disrupted […]

Read Next

Twelve Illinois scientists rank among the world’s most influential

Study shows new hope for commercially attractive lithium extraction from spent batteries

Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy